[go: up one dir, main page]

MX9702303A - Composiciones que contienen por lo menos un glucocorticoide en combinacion con un agente tensioactivo pulmonar para el tratamiento de sindromes de sufrimiento respiratorio infantil y sindrome de sufrimiento respiratorio agudo. - Google Patents

Composiciones que contienen por lo menos un glucocorticoide en combinacion con un agente tensioactivo pulmonar para el tratamiento de sindromes de sufrimiento respiratorio infantil y sindrome de sufrimiento respiratorio agudo.

Info

Publication number
MX9702303A
MX9702303A MX9702303A MX9702303A MX9702303A MX 9702303 A MX9702303 A MX 9702303A MX 9702303 A MX9702303 A MX 9702303A MX 9702303 A MX9702303 A MX 9702303A MX 9702303 A MX9702303 A MX 9702303A
Authority
MX
Mexico
Prior art keywords
acyloxysilane
foaming
containing silicone
silicone materials
bifunctionally
Prior art date
Application number
MX9702303A
Other languages
English (en)
Other versions
MXPA97002303A (es
Inventor
Paul-Georg Germann
Klaus Eistetter
Ulrich Kilian
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of MXPA97002303A publication Critical patent/MXPA97002303A/es
Publication of MX9702303A publication Critical patent/MX9702303A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)

Abstract

Se describen composiciones novedosas para el tratamiento de IRDS y ARDS, que contienen por lo menos un glucocorticoesteroide y un agente tensioactivo pulmonar. La duracion del tratamiento y la mortalidad asociada con esos síndromes pueden reducirse significativamente con las composiciones novedosas propuestas.
MX9702303A 1994-09-28 1995-09-27 Composiciones que contienen por lo menos un glucocorticoide en combinacion con un agente tensioactivo pulmonar para el tratamiento de sindromes de sufrimiento respiratorio infantil y sindrome de sufrimiento respiratorio agudo. MX9702303A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4434629A DE4434629C1 (de) 1994-09-28 1994-09-28 Zusammensetzungen zur Behandlung von IRDS und ARDS
DEP4434629.8 1994-09-28
PCT/EP1995/003816 WO1996009831A2 (de) 1994-09-28 1995-09-27 Zusammensetzungen zur behandlung von irds und ards, die mindestens ein glucocorticosteroid in kombination mit einem lungen surfactant enthalten

Publications (2)

Publication Number Publication Date
MXPA97002303A MXPA97002303A (es) 1997-06-01
MX9702303A true MX9702303A (es) 1997-06-28

Family

ID=6529394

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702303A MX9702303A (es) 1994-09-28 1995-09-27 Composiciones que contienen por lo menos un glucocorticoide en combinacion con un agente tensioactivo pulmonar para el tratamiento de sindromes de sufrimiento respiratorio infantil y sindrome de sufrimiento respiratorio agudo.

Country Status (25)

Country Link
US (1) US5891844A (es)
EP (1) EP0783314B1 (es)
JP (1) JP4425991B2 (es)
KR (1) KR100365030B1 (es)
CN (1) CN1100542C (es)
AT (1) ATE241372T1 (es)
AU (1) AU705099B2 (es)
BG (1) BG62556B1 (es)
CA (1) CA2201377C (es)
CZ (1) CZ292846B6 (es)
DE (2) DE4434629C1 (es)
DK (1) DK0783314T3 (es)
EE (1) EE03422B1 (es)
ES (1) ES2201120T3 (es)
FI (1) FI118886B (es)
HU (1) HU226958B1 (es)
MX (1) MX9702303A (es)
NO (1) NO313405B1 (es)
NZ (1) NZ294587A (es)
PL (1) PL187496B1 (es)
PT (1) PT783314E (es)
RU (1) RU2157222C2 (es)
SK (1) SK284446B6 (es)
UA (1) UA43378C2 (es)
WO (1) WO1996009831A2 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
EP0977577B1 (en) * 1997-02-17 2006-08-16 ALTANA Pharma AG Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6946117B1 (en) * 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
CN1194833A (zh) * 1997-10-08 1998-10-07 刘柏宏 肺活素
US6858223B2 (en) 1998-06-23 2005-02-22 Altana Pharma Ag Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
AU5400000A (en) * 1999-06-11 2001-01-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
WO2001019392A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
CA2405811C (en) * 2000-04-12 2011-09-27 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
RU2191031C2 (ru) * 2001-01-10 2002-10-20 Московский НИИ педиатрии и детской хирургии Способ лечения пневмоний у глубоконедоношенных детей, находящихся на искусственной вентиляции легких
DE10132307A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Arzneizubereitung zur Inhalation von Antithrombin bei entzündlichen Lungenerkrankungen und ARDS
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
AU2002357168A1 (en) * 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
ES2383206T3 (es) 2003-06-16 2012-06-19 Nycomed Gmbh Composición que comprende un tensioactivo pulmonar y sildenafilo para el tratamiento de neumopatías
DK1670482T4 (da) * 2003-09-16 2022-08-22 Covis Pharma B V Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
US7464012B2 (en) * 2004-12-10 2008-12-09 L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude Simplified process simulator
US7582312B2 (en) * 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
ATE538814T1 (de) 2005-01-06 2012-01-15 Discovery Lab Inc Dosierungsschema unter verwendung eines tensids zur behandlung oder verhinderung von lungendysplasien
KR100891595B1 (ko) * 2005-02-28 2009-04-03 주식회사 케이티앤지 혈액 단백질의 삼출을 감소시키는 조성물
RU2455021C2 (ru) * 2006-09-19 2012-07-10 Дискавери Лабораториз, Инк. Композиции легочных сурфактантов и способы их применения, содействующие очищению от слизи
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
WO2012077127A1 (en) * 2010-12-10 2012-06-14 Indian Institute Of Technology, Bombay A protein free surfactant composition for pulmonary diseases and a process for preparing the same
WO2013188016A2 (en) 2012-05-04 2013-12-19 Discovery Laboratories, Inc. Surfactant therapy for exposure to ionizing radiation
CN106310280A (zh) * 2016-08-18 2017-01-11 滨州医学院 地瑞那韦增强糖皮质激素抗炎作用的医药新用途
CN110099695B (zh) * 2016-12-22 2022-01-25 奇斯药制品公司 用于治疗进展性bpd的包含肺表面活性物质和类固醇的治疗组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01501455A (ja) * 1986-08-08 1989-05-25 クルジンスキー，キャス　アール 鋼スラブを連続的に鋳造するための装置および方法
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
RU2039560C1 (ru) * 1988-04-18 1995-07-20 Центр по химии лекарственных средств ВНИИХФИ Вещество, обладающее противоопухолевой активностью
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances

Also Published As

Publication number Publication date
CZ94097A3 (en) 1997-09-17
FI118886B (fi) 2008-04-30
HUT77931A (hu) 1998-11-30
PL187496B1 (pl) 2004-07-30
RU2157222C2 (ru) 2000-10-10
PL319608A1 (en) 1997-08-18
CZ292846B6 (cs) 2003-12-17
NO971403L (no) 1997-04-17
EE03422B1 (et) 2001-06-15
JPH10506119A (ja) 1998-06-16
AU705099B2 (en) 1999-05-13
CN1100542C (zh) 2003-02-05
DK0783314T3 (da) 2003-12-01
CN1163571A (zh) 1997-10-29
KR970706006A (ko) 1997-11-03
DE59510705D1 (de) 2003-07-03
BG101441A (en) 1997-09-30
FI971277L (fi) 1997-05-27
FI971277A0 (fi) 1997-03-26
UA43378C2 (uk) 2001-12-17
NO971403D0 (no) 1997-03-25
EP0783314A2 (de) 1997-07-16
JP4425991B2 (ja) 2010-03-03
US5891844A (en) 1999-04-06
SK40197A3 (en) 1998-02-04
CA2201377C (en) 2008-07-29
HK1003869A1 (en) 1998-11-13
ES2201120T3 (es) 2004-03-16
NZ294587A (en) 1998-07-28
BG62556B1 (bg) 2000-02-29
DE4434629C1 (de) 1996-06-27
EP0783314B1 (de) 2003-05-28
KR100365030B1 (ko) 2003-03-10
AU3742895A (en) 1996-04-19
ATE241372T1 (de) 2003-06-15
WO1996009831A2 (de) 1996-04-04
HU226958B1 (en) 2010-03-29
NO313405B1 (no) 2002-09-30
CA2201377A1 (en) 1996-04-04
PT783314E (pt) 2003-10-31
WO1996009831A3 (de) 1996-05-23
SK284446B6 (sk) 2005-04-01
EE9700084A (et) 1997-10-15

Similar Documents

Publication Publication Date Title
MX9702303A (es) Composiciones que contienen por lo menos un glucocorticoide en combinacion con un agente tensioactivo pulmonar para el tratamiento de sindromes de sufrimiento respiratorio infantil y sindrome de sufrimiento respiratorio agudo.
SI0797439T1 (en) Use of pramipexole as a neuroprotective agent
GR3032161T3 (en) Amido siladiyl bridged catalyst components, methods of making and using
AU8893191A (en) Hair styling composition
DE69402043D1 (de) Verfahrenshilfsmittel für gaserzeugende Zusammensetzungen
ATE183916T1 (de) Applikationssystem
HU9503370D0 (en) N-alkylthio polyamine derivatives as radioprotective agents
GR3029700T3 (en) Process for foaming acyloxysilane-containing silicone materials
AU6660694A (en) Use of a vinyl lactam derived terpolymer as foaming agent inaerosol foam-forming compositions, and composition thereby obtained
EP0638851A3 (en) Separable sealing element, development apparatus and process cartridge.
ZA914567B (en) Process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide
SG55092A1 (en) Fire retardant agents suitable for plastics
AP9100296A0 (en) Peptides and analogues and mixtures thereof for detecting antibodies to HTLV-1 and HTLV11 viruses.
ZA852495B (en) Anticonvulsant agents
DE59801711D1 (de) Geschlossenporige siliconschäume, verfahren zu ihrer herstellung und ihre verwendung
AU6206486A (en) P-acylaminobenzamides
NO985111L (no) Eksplosiv formulering
EP0647654A3 (es)
HUT76869A (en) Improved process for making sulfonyl isocyanates
FR2703262B1 (fr) Mélanges gazeux.
MX9602767A (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina.
UA29914A (uk) Спосіб моделювання токсичного гепатиту
ES285464U (es) Dispositivo de parachoques, particularmente destinado a un vehiculo
IT1256925B (it) Impiego di frammenti o/e di derivati della timosina alfa 1.
TW227527B (en) An aniline offshoot condenser's divergent agent and synthesizing method